← Eichor
Study identifier: NCT06727006 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Rescue Stenting and Intravenous Thrombolysis In Patients With Large Vessel Ischemic Stroke

Condition: Large Vessel Occlusion · Stroke Acute · Thrombolysis  ·  Sponsor: ASST Santi Paolo e Carlo

PhaseN/A
Planned participants400
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are the standard of care for treating selected patients with acute large-vessel occlusion stroke (LVOS). Successful revascularization is strongly correlated with favorable outcomes. Nevertheless, recanalization failure with stent retrieval and contact aspiration has been observed in up to 29% of patients. If primary thrombectomy fails to achieve recanalization, rescue stenting (RS) has proven to be a feasible rescue therapy. Currently, approved evidence-based alternatives for LVOS patients who have failed MT are lacking, but permanent stenting is suggested as a rescue treatment in expert consensus statements. Dual antiplatelet therapy (DAPT), typically consisting of clopidogrel and aspirin, is recommended after stent implantation to reduce the risk of stent thrombosis; however, these medications are not suitable in the acute setting, and optimal platelet inhibition strategies remain unclear. Glycoprotein (GP) IIb/IIIa receptor inhibitors have intravenous administration, a rapid onset of action, and their effects subside within a few hours after discontinuation. For these reasons, an increasing number of studies have investigated their use in conjunction with primary stenting for acute stroke. Currently, there is no evidence supporting the superiority of any particular antithrombotic strategy, so decisions are guided by clinical judgment. An additional challenge for clinicians arises when IVT is combined with st…

This description comes directly from the study's public registry record.

Talk to the study team

Elena Ballabio, Medical Doctor  ·  +393470772687  ·  elena.ballabio@asst-santipaolocarlo.it

Luca Valvassori, MD  ·  +393395947715  ·  luca.valvassori@asst-santipaolocarlo.it

Always discuss trial participation with your own doctor first.

Locations (7)

ASST Papa Giovanni XXIIIBergamo, Italy, ItalyRecruiting
Ospedale BufaliniCesena, Italy, ItalyRecruiting
Azienda Sanitaria Lecce - Ospedale "Vito Fazzi"Lecce, Italy, ItalyRecruiting
ASST Santi Paolo e CarloMilan, Italy, ItalyRecruiting
ASST Grande Ospedale Metropolitano NiguardaMilan, Italy, ItalyRecruiting
Fondazione IRCCS San Gerardo dei TintoriMonza, Italy, ItalyRecruiting
ASL 2 Savonese - Ospedale Santa CoronaPietra Ligure, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06727006